HUM stock news · Humana Inc.
Get alerts for HUM
Follow Humana Inc. (HUM) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for HUMUnitedHealth says 2026 will be the worst year for its Medicaid profits.
Good for HUMHumana's plans received five- and four-star CMS ratings, and the company spoke positively about its 2027 and 2028 outlook.
Humana Inc. shares news about a new partnership with BlackRock to run senior care clinics.
Good for HUMHumana's new clinic deal is expected to cut related liabilities and financing costs. That helps its finances, though its 2026 adjusted profit target is unchanged.
The Dow climbed more than 400 points this week as investors feel more positive, moving the Fear & Greed Index to ‘Neutral’.
Good for HUMHumana reported better 2027 Medicare Advantage ratings, with 95% of members in plans rated at least 4 stars. This supports its business, though the story gives no added-income estimate.
The Dow climbed more than 400 points this week as investors feel more positive, moving the Fear & Greed Index to ‘Neutral’.
Good for HUMHumana said its 2027 Medicare Advantage ratings improved, with 95% of members in plans earning at least 4 stars. That may help its plans compete for members.
Humana, Evolution Metals, Fastly, and other major stocks rose on Friday.
Good for HUMHumana’s Medicare Advantage ratings improved, and it kept its 2026 adjusted profit forecast unchanged. Together, these updates support a favorable view of the company.
12 health care stocks are changing a lot before the market opens on Friday.
NeutralHumana shares rose 16.2% before Friday’s market opened. The article gives no company news explaining the move, so it does not change Humana’s outlook.
12 health care companies saw big changes in their stock prices after the market closed on Thursday.
NeutralHumana shares rose 14% after hours, but the article gives no business reason or new company news. It does not change Humana's outlook.
Mark Cuban's drug pricing strategy gains support from Bill Ackman: Potential winners and losers among healthcare stocks emerge.
Good for HUMBill Ackman has endorsed Mark Cuban's proposals for more transparent drug pricing, which could impact several healthcare companies as the industry adapts to potential changes in pharmacy benefit management and pricing structures.
Overnight decline in CVRx shares attributed to lowered revenue forecasts.
NeutralHumana's new Medicare Advantage coverage policy for Barostim therapy is noted as a significant reimbursement milestone for CVRx.